rxstat › Drug prices › Bevacizumab

Bevacizumab (Abevmy, Aybintio) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Nov 16, 2026

Also sold as: Abevmy, Aybintio, Bambevi, Mvasi

Bevacizumab 400 mg/16ml solution costs about $30.44 per mL on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. The brand (Abevmy) lists at $36.73. It is not a covered benefit on the public plans we track; the price shown is a list price.

Bevacizumab has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formAB
400 mg/16ml Solutionper mL$30.44not coveredbrand $36.73
100 mg/4ml Solutionper mL$30.50not coveredbrand $36.73
25 mg/ml Solutionper mL$30.44not covered
Plan coverageNot covered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 13 products
  • Aybintio 400 mg/16ml Solution · SSB
    DIN 02522837 · $30.44/mL · Not covered
  • Bambevi 400 mg/16ml Solution · APX
    DIN 02520737 · $30.44/mL · Not covered
  • Mvasi 25 mg/ml Solution · AMG
    DIN 02470756 · $30.44/mL · Not covered
  • Vegzelma 400 mg/16ml Solution · CHC
    DIN 02534185 · $30.44/mL · Not covered
  • Zirabev 400 mg/16ml Solution · PFI
    DIN 02489449 · $30.44/mL · Not covered
  • Aybintio 100 mg/4ml Solution · SSB
    DIN 02522829 · $30.50/mL · Not covered
  • Bambevi 100 mg/4ml Solution · APX
    DIN 02520729 · $30.50/mL · Not covered
  • Mvasi 25 mg/ml Solution · AMG
    DIN 02470748 · $30.50/mL · Not covered
  • Vegzelma 100 mg/4ml Solution · CHC
    DIN 02534177 · $30.50/mL · Not covered
  • Zirabev 100 mg/4ml Solution · PFI
    DIN 02489430 · $30.50/mL · Not covered
  • Abevmy 400 mg/16ml Solution · BBC
    DIN 02522160 · $36.73/mL · Not covered
  • Abevmy 100 mg/4ml Solution · BBC
    DIN 02522179 · $36.73/mL · Not covered
  • Avastin 25 mg/ml Solution · HLR
    DIN 02270994 · $129.79/mL · Not covered

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

No shortage or discontinuation reports have been filed with Health Canada for Bevacizumab. rxstat watches those reports through the day; sign up below to hear if that changes.

Common questions

How much does Bevacizumab cost in Canada?

Bevacizumab 400 mg/16ml solution costs about $30.44 per mL on public drug plan price lists in Alberta, before the pharmacy's dispensing fee. The brand (Abevmy) lists at $36.73. It is not a covered benefit on the public plans we track; the price shown is a list price.

Is Bevacizumab covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.